Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Mirum Pharmaceuticals
MIRM
$6.39B
| $646K | ﹤0.01% |
+29,319
| New | +$598K |
|
2627
NOV
NOV
$6.91B
| $646K | ﹤0.01% |
+32,985
| New | +$577K |
|
2628
Rush Enterprises Class B
RUSHB
$6.16B
| $645K | ﹤0.01% |
20,044
-10,158
| -34% | -$337K |
|
2629
Agilysys
AGYS
$3.09B
| $640K | ﹤0.01% |
16,052
-11,538
| -42% | -$463K |
|
|
CANO.WS
2630
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
| $640K | ﹤0.01% |
+405,000
| New | +$584K |
|
2631
Repay Holdings
RPAY
$339M
| $639K | ﹤0.01% |
+43,253
| New | +$714K |
|
2632
World Acceptance Corp
WRLD
$876M
| $639K | ﹤0.01% |
3,329
-2,309
| -41% | -$458K |
|
2633
Nu Skin
NUS
$252M
| $637K | ﹤0.01% |
13,326
-69,895
| -84% | -$3.46M |
|
|
NGD
2634
DELISTED
New Gold Inc
NGD
| $636K | ﹤0.01% |
353,270
+318,059
| +903% | +$547K |
|
2635
Southern First Bancshares
SFST
$599M
| $636K | ﹤0.01% |
12,512
-7,827
| -38% | -$449K |
|
2636
Invesco Solar ETF
TAN
$1.45B
| $634K | ﹤0.01% |
8,404
-91,511
| -92% | -$6.32M |
|
2637
Unitil
UTL
$966M
| $634K | ﹤0.01% |
12,721
-11,666
| -48% | -$570K |
|
|
TRON
2638
DELISTED
Corner Growth Acquisition Corp. 2 Class A Ordinary Share
TRON
| $634K | ﹤0.01% |
+63,700
| New | +$631K |
|
2639
American Vanguard Corp
AVD
$71.5M
| $632K | ﹤0.01% |
31,083
-16,375
| -35% | -$268K |
|
2640
Americold
COLD
$4.01B
| $631K | ﹤0.01% |
22,663
-150,571
| -87% | -$4.23M |
|
2641
Broadstone Net Lease
BNL
$4.06B
| $630K | ﹤0.01% |
+28,933
| New | +$646K |
|
2642
First Community Bankshares
FCBC
$909M
| $630K | ﹤0.01% |
22,294
-17,441
| -44% | -$535K |
|
2643
Hamilton Lane
HLNE
$5.25B
| $629K | ﹤0.01% |
8,126
-45,774
| -85% | -$3.82M |
|
2644
MBIA
MBI
$269M
| $628K | ﹤0.01% |
40,820
-53,391
| -57% | -$786K |
|
2645
Myers Industries
MYE
$1.38B
| $628K | ﹤0.01% |
29,067
-18,104
| -38% | -$330K |
|
2646
Accel Entertainment
ACEL
$974M
| $625K | ﹤0.01% |
+51,310
| New | +$663K |
|
2647
GH Research
GHRS
$1.94B
| $624K | ﹤0.01% |
+34,092
| New | +$602K |
|
2648
Great Southern Bancorp
GSBC
$889M
| $624K | ﹤0.01% |
10,574
-8,084
| -43% | -$487K |
|
2649
HealthStream
HSTM
$833M
| $624K | ﹤0.01% |
31,352
-10,706
| -25% | -$242K |
|
2650
Vanguard Financials ETF
VFH
$13.6B
| $624K | ﹤0.01% |
6,680
| – | – |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.